Patent · US Expired

Formulation for the oromucosal, in particular pernasal, route

US6326401A · kind A · utility

2Cited by

0References

20Claims

0Family size

Assignee

Immunotech · FR

Inventors

Jacques Chauveau · Marseille, FR
Pascal Meyer · Marseilles, FR
Jacques Barbet · Nantes, FR
Michel Delaage · Marseilles, FR

Key dates

Filing date	Jan 6, 1999
Grant date	Dec 4, 2001
Priority date	—
Expiry date	Jan 6, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A liquid pharmaceutical formulation for administration by the oro-mucosal route, comprising at least one non-polypeptidic active substance and less than 5% W/W of capryl caproyl macrogol glycerides, process for its preparation and it uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.